Dieppe mom wants $350K drug covered for son
Dominic Melanson suffers from spinal muscular atrophy, a rare condition that gradually deteriorates his motor skills. He is taking the drug Spinraza as part of a trial experiment. Dominic Melanson suffers from spinal muscular atrophy, a rare condition that gradually deteriorates his motor skills. Last year, Health Canada approved Spinraza to treat spinal muscular atrophy. Melanson is pleading for for the government to cover it for everyone with spinal muscular atrophy, including her son.
Source: CBC News April 29, 2018 20:37 UTC
/https://www.thestar.com/content/dam/thestar/sports/raptors/2018/04/29/raptors-will-face-lebron-james-and-cavaliers-in-round-two-of-nba-playoffs/lebron_pacers_game_7.jpg)
/https://www.thestar.com/content/dam/thestar/business/tech_news/2018/04/29/us-telecoms-sprint-and-t-mobile-to-combine-into-new-company/sprint_t_mobile.jpg)